Cited 0 time in
Caveolin-2 controls preadipocyte survival in the mitotic clonal expansion for adipogenesis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Moonjeong | - |
| dc.contributor.author | Jeong, Kyuho | - |
| dc.contributor.author | Pak, Yunbae | - |
| dc.date.accessioned | 2024-12-03T00:30:48Z | - |
| dc.date.available | 2024-12-03T00:30:48Z | - |
| dc.date.issued | 2024-10 | - |
| dc.identifier.issn | 0167-4889 | - |
| dc.identifier.issn | 1879-2596 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/73439 | - |
| dc.description.abstract | Here, we report that Caveolin-2 (Cav-2) is a cell cycle regulator in the mitotic clonal expansion (MCE) for adipogenesis. For the G2/M phase transition and re-entry into the G1 phase, dephosphorylated Cav-2 by protein tyrosine phosphatase 1B (PTP1B) controlled epigenetic activation of Ccnb1, Cdk1, and p21 in a lamin A/C-dependent manner, thereby ensuring the survival of preadipocytes. Cav-2, associated with lamin A/C, recruited the repressed promoters of Ccnb1 and Cdk1 for activation, and disengaged the active promoter of p21 from lamin A/C for inactivation through histone H3 modifications at the nuclear periphery. Cav-2 deficiency abrogated the histone H3 modifications and impeded the transactivation of Ccnb1, Cdk1, and p21, leading to a delay in mitotic entry, retardation of re-entry into G1 phase, and the apoptotic cell death of preadipocytes. Re-expression of Cav-2 restored the G2/M phase transition and G1 phase re-entry, preadipocyte survival, and adipogenesis in Cav-2-deficient preadipocytes. Our study uncovers a novel mechanism by which cell cycle transition and apoptotic cell death are controlled for adipocyte hyperplasia. © 2024 Elsevier B.V. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Caveolin-2 controls preadipocyte survival in the mitotic clonal expansion for adipogenesis | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.bbamcr.2024.119793 | - |
| dc.identifier.scopusid | 2-s2.0-85199166347 | - |
| dc.identifier.wosid | 001280670900001 | - |
| dc.identifier.bibliographicCitation | Biochimica et Biophysica Acta - Molecular Cell Research, v.1871, no.7 | - |
| dc.citation.title | Biochimica et Biophysica Acta - Molecular Cell Research | - |
| dc.citation.volume | 1871 | - |
| dc.citation.number | 7 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | BINDING PROTEIN-BETA | - |
| dc.subject.keywordPlus | C/EBP-BETA | - |
| dc.subject.keywordPlus | ADIPOCYTE DIFFERENTIATION | - |
| dc.subject.keywordPlus | PHOSPHORYLATION SITES | - |
| dc.subject.keywordPlus | ONCOGENIC RAS | - |
| dc.subject.keywordPlus | ACTIVATION | - |
| dc.subject.keywordPlus | P53 | - |
| dc.subject.keywordAuthor | Adipogenesis | - |
| dc.subject.keywordAuthor | Apoptosis | - |
| dc.subject.keywordAuthor | Caveolin-2 | - |
| dc.subject.keywordAuthor | Cell cycle | - |
| dc.subject.keywordAuthor | Lamin A/C | - |
| dc.subject.keywordAuthor | Mitotic clonal expansion | - |
| dc.subject.keywordAuthor | PTP1B | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
